Featured Research

from universities, journals, and other organizations

Enzymatic Activity Of Factors Involved In Childhood Leukemia Clarified

Date:
May 4, 2009
Source:
Stowers Institute for Medical Research
Summary:
Researchers have provided new insight into the molecular basis for H3K4 methylation, an activity associated with the MLL protein found in chromosomal translocation-based aggressive infant acute leukemias.

Researchers have provided new insight into the molecular basis for H3K4 methylation, an activity associated with the MLL protein found in chromosomal translocation-based aggressive infant acute leukemias.

Studies describing these collaborative studies by The Stowers Institute's Shilatifard Lab and colleagues were published online by Molecular and Cellular Biology and Cell this week.

Many hematological malignancies are associated with a genetic error in which a portion of one chromosome has broken and fused with another chromosome. This inappropriate fusion of chromosomal DNA is referred to as chromosomal translocation. A large proportion of infant leukemias are the result of chromosomal translocations in the Mixed Lineage Leukemia (MLL) gene. Children suffering from these chromosomal translocations have low survival rates and face treatment options that have devastating side effects.

The Stowers Institute's Shilatifard Lab studies chromosomal translocations related to the MLL gene. Several years ago, they identified a molecular complex – COMPASS – containing the yeast homologue of the human MLL. COMPASS was the first H3K4 methylase to be identified, and human MLL is also found in COMPASS-like complexes capable of methylating H3K4, a posttranslational modification marking chromosomes for transcription.

"We observed that the addition of three methyl groups (a process known as trimethylation) on the fourth lysine of H3K4 is regulated by the active site of the yeast equivalent of the MLL protein complex, COMPASS," said Yoh-hei Takahashi, Ph.D., Postdoctoral Research Associate and first author on the publication in Molecular and Cellular Biology. "We also demonstrated that a single residue (Tyr1052) functions with a known subunit of COMPASS (Cps40) to regulate the trimethylation of H3K4."

"These are exciting findings because each of these are significant steps that lead to unraveling how translocations cause leukemia and how we can develop treatments that better target and cure leukemia," said Ali Shilatifard, Ph.D., Investigator and senior author on the publication.

Additional contributing authors to the study published in Molecular and Cellular Biology from the Stowers Institute include Jung Shin Lee, Ph.D., Postdoctoral Research Associate; Selene Swanson, Research Specialist II; Anita Saraf, M.D., Ph.D., Senior Proteomics Scientist; Laurence Florens, Ph.D., Managing Director of Proteomics; and Michael Washburn, Ph.D., Director of Proteomics Center. Raymond Trievel, Ph.D., of the University of Michigan also contributed.

The Shilatifard Lab also has collaborated with Robert Roeder and colleagues at The Rockefeller University on a publication in Cell that sheds new light on the process of communication between histones known as histone crosstalk. This process has been a topic of interest to the Shilatifard Lab for many years, and they have made a number of important contributions to its understanding.

Through a series of laborious biochemical and genetic screens in yeast and over five years of work, the Shilatifard Lab identified the molecular machinery required for proper H3K4 methylation by COMPASS. This includes the modification of histone H2B by attaching a single ubiquitin – a regulatory protein that is very similar from species to species – by the Rad6/Bre1 complex in a process called histone crosstalk. In the Cell publication, the team demonstrated that human Rad6/Bre1 also functions in histone crosstalk as it does in yeast.

"This study demonstrates the awesome power of simple genetic and biochemical model systems such as yeast in deciphering molecular machinery involved in chromatin biology and how yeast can play a role as a template in identifying the human counterparts of these proteins," said Dr. Shilatifard. "Indeed, as reported this week in Cell, human Rad6 can functionally replace yeast Rad6, and H2B monoubiquitination in humans functions by the same histone crosstalk mechanism as it does in yeast, demonstrating the conservation in this system from yeast to humans."

Jung-Shin Lee, Ph.D., Postdoctoral Research Associate in the Shilatifard Lab also contributed to this paper. Authors from The Rockefeller University include Jaehoon Kim, Ph.D., Mohamed Guermah, Robert McGinty, Zhanyun Tang, Ph.D., Thomas Milne, Ph.D., and Tom Muir, Ph.D.


Story Source:

The above story is based on materials provided by Stowers Institute for Medical Research. Note: Materials may be edited for content and length.


Journal References:

  1. Yoh-Hei Takahashi, Jung Shin Lee, Selene K. Swanson, Anita Saraf, Laurence Florens, Michael P. Washburn, Raymond C. Trievel, and Ali Shilatifard. Regulation of H3K4 trimethylation via Cps40 (Spp1) of COMPASS is monoubiquitination-independent: Implication for a Phe/Tyr switch by the catalytic domain of Set1. Molecular and Cellular Biology, 2009; DOI: 10.1128/MCB.00013-09
  2. Jaehoon Kim, Mohamed Guermah, Robert K. McGinty, Jung-Shin Lee, Zhanyun Tang, Thomas A. Milne, Ali Shilatifard, Tom W. Muir, Robert G. Roeder. RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells. Cell, 2009; 137 (3): 459 DOI: 10.1016/j.cell.2009.02.027

Cite This Page:

Stowers Institute for Medical Research. "Enzymatic Activity Of Factors Involved In Childhood Leukemia Clarified." ScienceDaily. ScienceDaily, 4 May 2009. <www.sciencedaily.com/releases/2009/05/090504141839.htm>.
Stowers Institute for Medical Research. (2009, May 4). Enzymatic Activity Of Factors Involved In Childhood Leukemia Clarified. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/05/090504141839.htm
Stowers Institute for Medical Research. "Enzymatic Activity Of Factors Involved In Childhood Leukemia Clarified." ScienceDaily. www.sciencedaily.com/releases/2009/05/090504141839.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins